<DOC>
	<DOCNO>NCT02334813</DOCNO>
	<brief_summary>Patients age 18 first episode immune thrombocytopenia randomize 1:1 2-4 week daily prednisone ( 1 mg/kg/d ) subsequent dose tapering ( arm A ) six 3-week cycle pulse dexamethasone ( 0.6 mg/kg/d , day 1-4 ; arm B ) . The primary endpoint duration remission define platelet ≥50/nl .</brief_summary>
	<brief_title>Daily Prednisone Versus Pulsed Dexamethasone Treatment-naïve Adult Patients With Immune Thrombocytopenia</brief_title>
	<detailed_description>Patients age 18 year first episode immune thrombocytopenia ( ITP ) eligible inclusion , except pregnant woman patient unable tolerate glucocorticoid . Diagnosis make treatment requirement define accord 1996 practice guideline American Society Hematology . The primary endpoint duration remission define platelet ≥50/nl . Secondary endpoint response rate , complete remission ( platelet ≥150/nl ) , cumulative cortisol equivalent dose ( potency prednisone / dexamethasone relative cortisol : x 4 / x 30 ) adverse event . During first week treatment patient receive prednisone 1 mg/kg/d . This period use confirm diagnosis identify patient ITP secondary lymphoproliferative , autoimmune ( systemic lupus erythematosus , antiphospholipid syndrome ) infectious disease ( human immunodeficiency , hepatitis C , cytomegalovirus infection ) . Patients stratified age ( cut-off : 50 year ) , gender primary versus secondary ITP randomize 1:1 daily prednisone ( arm A ) pulse dexamethasone ( arm B ) . In arm A prednisone continue 1 mg/kg/d second week . If platelet increase ≥50/nl , dose reduce &lt; 25 mg/d week 14 &lt; 7.5 mg/d week 20 accord step-wise reduction scheme provide protocol . In patient without response 2 week treatment , prednisone dose increase 2 mg/kg/d another 2 week , taper describe . In arm B patient receive six 21-day course pulse dexamethasone ( 0.6 mg/kg/d , day 1-4 ) . Patients fail achieve maintain remission switch alternative treatment arm ( A : response 4 week prednisone 1-2 mg/kg/d , loss response , maintenance dos exceed limit ; B : response 2 cycle , loss response ) .</detailed_description>
	<mesh_term>Thrombocytopenia</mesh_term>
	<mesh_term>Purpura</mesh_term>
	<mesh_term>Purpura , Thrombocytopenic , Idiopathic</mesh_term>
	<mesh_term>Purpura , Thrombocytopenic</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>First episode ITP Pregnancy Glucocorticoid intolerance</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>